EUVIMEDEUVIMED entdecken
Crossref

Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer

G. Oner, M. Praet, G. Devi, N.Z. Canturk, S. Altintas, Z. Berneman, W. Tjalma, S. Koljenovic, P.A. van Dam

European Journal of Cancer · 2026-03 · 237 · 116356

DOI: 10.1016/j.ejca.2026.116356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von G. Oner und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Oner, G., Praet, M., Devi, G., Canturk, N., Altintas, S., Berneman, Z., Tjalma, W., Koljenovic, S., & Dam, P. V. (2026). Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer. European Journal of Cancer, 237, 116356. https://doi.org/10.1016/j.ejca.2026.116356

Vancouver

Oner G, Praet M, Devi G, Canturk N, Altintas S, Berneman Z, et al. Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer. European Journal of Cancer. 2026;237:116356. doi:10.1016/j.ejca.2026.116356

BibTeX
@article{Oner2026,
  author = {Oner, G. and Praet, M. and Devi, G. and Canturk, N.Z. and Altintas, S. and Berneman, Z. and Tjalma, W. and Koljenovic, S. and Dam, P.A. van},
  title = {Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116356},
  doi = {10.1016/j.ejca.2026.116356}
}
Kostenlos starten →